Literature DB >> 15304238

Identification of the role of presenilins beyond Alzheimer's disease.

Gopal Thinakaran1, Angèle T Parent.   

Abstract

Mutations in the genes encoding presenilin 1 (PS1) and presenilin 2 (PS2) account for the majority of the cases of familial early-onset Alzheimer's disease (FAD). Presenilins (PSs) facilitate the intramembraneous cleavage of amyloid precursor protein (APP), coined gamma-secretase cleavage, which generates beta-amyloid peptides (A beta). Considerable evidence suggests that FAD-linked PS variants exert their pathogenic influence by selectively elevating the levels of highly fibrillogenic A beta 42 peptides. In addition, numerous other functions have been ascribed to PSs based on subcellular localization, protein interactions, loss of function studies, and intramembraneous gamma-secretase cleavage of growing number of substrates. This review summarizes the diverse physiological functions that are regulated by PSs beyond APP metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304238     DOI: 10.1016/j.phrs.2003.12.026

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  22 in total

Review 1.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

2.  Presenilins regulate the cellular level of the tumor suppressor PTEN.

Authors:  Han Zhang; Runzhong Liu; Ruishan Wang; Shuigen Hong; Huaxi Xu; Yun-wu Zhang
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

3.  Steady-state increase of cAMP-response element binding protein, Rac, and PAK signaling in presenilin-deficient neurons.

Authors:  Natalie Y Barnes; Jun Shi; Hiroshi Yajima; Gopal Thinakaran; Angèle T Parent
Journal:  J Neurochem       Date:  2007-11-07       Impact factor: 5.372

4.  Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.

Authors:  Hien T Tran; Frank M LaFerla; David M Holtzman; David L Brody
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

Review 5.  Presenilins and the gamma-secretase: still a complex problem.

Authors:  David H Small; David W Klaver; Lisa Foa
Journal:  Mol Brain       Date:  2010-02-05       Impact factor: 4.041

6.  Mutations of presenilin genes in dilated cardiomyopathy and heart failure.

Authors:  Duanxiang Li; Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Julie Partain; Randal R Nixon; Charles N Allen; Robert P Irwin; Petra M Jakobs; Michael Litt; Ray E Hershberger
Journal:  Am J Hum Genet       Date:  2006-10-24       Impact factor: 11.025

7.  Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes.

Authors:  Kulandaivelu S Vetrivel; Haipeng Cheng; William Lin; Takashi Sakurai; Tong Li; Nobuyuki Nukina; Philip C Wong; Huaxi Xu; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

8.  Modeling presenilin-dependent familial Alzheimer's disease: emphasis on presenilin substrate-mediated signaling and synaptic function.

Authors:  Angèle T Parent; Gopal Thinakaran
Journal:  Int J Alzheimers Dis       Date:  2010-07-20

9.  Mutant presenilin 1 expression in excitatory neurons impairs enrichment-mediated phenotypes of adult hippocampal progenitor cells.

Authors:  Karthikeyan Veeraraghavalu; Sangram S Sisodia
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

10.  Current experimental therapy for Alzheimer's disease.

Authors:  Sheng Chen; Xiao-Jie Zhang; Liang Li; Wei-Dong Le
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.